Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	38,090	26,384	-	-	-
Enterprise Value	40,435	28,925	-	-	-
Last Close Price	31.48	22.43	-	-	-
PE Ratio	100.77	114.22	-	-	-
PS Ratio	8.12	5.94	-	-	-
PB Ratio	4.93	3.39	-	-	-
P/FCF Ratio	45.13	73.29	-	-	-
P/OCF Ratio	40.05	54.07	-	-	-
EV/Sales Ratio	8.78	6.52	-	-	-
EV/EBITDA Ratio	40.67	32.46	-	-	-
EV/EBIT Ratio	55.45	43.11	-	-	-
EV/FCF Ratio	47.91	80.35	-	-	-
Debt / Equity Ratio	0.37	0.35	0.91	1.27	1.25
Debt / EBITDA Ratio	2.81	3.00	5.83	8.68	9.67
Debt / FCF Ratio	3.37	7.66	111.57	583.27	39.02
Asset Turnover	0.37	0.35	0.33	0.31	-
Inventory Turnover	3.15	3.29	2.86	3.03	-
Quick Ratio	0.76	0.89	0.72	0.52	0.55
Current Ratio	1.09	1.21	1.03	0.77	0.82
Return on Equity (ROE)	4.92%	3.51%	-1.16%	-2.15%	-
Return on Assets (ROA)	3.65%	3.34%	3.04%	2.01%	-
Return on Capital (ROIC)	4.39%	4.03%	3.71%	2.46%	-
Return on Capital Employed (ROCE)	6.70%	6.10%	5.60%	3.80%	3.30%
Earnings Yield	0.99%	0.88%	-	-	-
FCF Yield	2.22%	1.36%	-	-	-
Buyback Yield / Dilution	-0.11%	-0.10%	95.42%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.